Comphya, a Swiss medical device company, is developing the first implantable neurostimulator to treat erectile dysfunction (ED). The device, CaverSTIM, aims to…
To compare males and females who were stratified into subgroups corresponding to premenopausal, perimenopausal and postmenopausal ages, regarding access to optimal care…
Indigenous peoples with a spinal cord injury across Canada have different physical, social, and environmental challenges than non-Indigenous populations. More resources should…
Praxis is pleased to participate in this year’s in-person conference, sharing the latest research and developments from the Institute and our partners…
Spinal Cord Stimulation (SCS) is a therapeutic approach used within the research setting with considerable evidence to address the sensory, motor, and…
